Literature DB >> 16173677

Rotation direction change hastens motion sickness onset in an optokinetic drum.

Frederick Bonato1, Andrea Bubka, Meredith Story.   

Abstract

BACKGROUND: Many stationary subjects who view the patterned interior of a rotating cylinder (optokinetic drum) experience motion sickness (MS) symptoms. An experiment was conducted to investigate the effects of rotation direction change on MS onset and severity. It was predicted that intermittently changing rotation direction would hasten MS onset due to an increased degree of visual/vestibular sensory conflict.
METHODS: There were 12 individuals who participated in the experiment (4 men, 8 women, mean age = 24.4 yr). Subjects viewed the interior of an optokinetic drum that rotated at 5 rpm (30 degrees x s(-1)). Drum rotation was either consistently in the same direction or rotation direction changed every 30 s. Eight MS symptoms were assessed at 2-min intervals using a subjective scale (0 = none, 1 = slight, 2 = moderate, 3 = severe).
RESULTS: Overall, MS onset was fastest when drum rotation direction changed. Specific MS symptoms significantly affected were dizziness, stomach awareness, and nausea.
CONCLUSIONS: These results suggest that a lack of correlation between the sensed and expected effects of motion alone can lead to MS. These results cannot be accounted for by a lack of correlation between sensed and expected gravitational vertical given that these were held constant across conditions.

Entities:  

Mesh:

Year:  2005        PMID: 16173677

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  2 in total

1.  Vection and visually induced motion sickness: how are they related?

Authors:  Behrang Keshavarz; Bernhard E Riecke; Lawrence J Hettinger; Jennifer L Campos
Journal:  Front Psychol       Date:  2015-04-20

2.  Vection is the main contributor to motion sickness induced by visual yaw rotation: Implications for conflict and eye movement theories.

Authors:  Suzanne A E Nooij; Paolo Pretto; Daniel Oberfeld; Heiko Hecht; Heinrich H Bülthoff
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.